EXTRACORPOREAL HEART AND LUNG TREATMENTS
We offer extracorporeal membrane oxygenation (ECMO) treatments for patients suffering from cardiac and/or pulmonary failure. Based on a holistic understanding of human physiology, we develop extracorporeal life support (ECLS) technologies that can be vital for the survival of critically ill patients.[1-3]
We provide solutions that combine both cardiac and pulmonary support on one single technological platform, the Xenios console. It supports gas exchange in the lungs and the cardiovascular system. ECMO thus provides physicians with crucial time for diagnosis and therapy.[1]
Xenios is part of Fresenius Medical Care, the world’s leading provider of products and services for people with renal diseases. As human organs are a mutually linked system, Fresenius Medical Care pursues a multi-organ support approach in Critical Care, drawing on its extensive expertise in extracorporeal blood treatment for acute kidney injury.
We are complementing Fresenius Medical Care’s product portfolio in the field of intensive care and are continuing to shape the future of extracorporeal multi-organ support.
In our daily work, we share a passion for helping people.
For patients. Worldwide. Every day.
BY
YOUR
SIDE
GET IN TOUCH WITH US!
Find the right person for your topic with our contact form.
Heart & Lung Campus
Join, Learn, Care
Looking for further treatment and product information?
Join our Heart & Lung Campus to explore various e-learning modules, for example expert interviews, best-practice-cases, medical information, hands-on-tutorials and priming instructions.
On demand, 24 hours a day, 7 days a week – whenever you need it.
News
News
5.000 followers on LinkedIn – Thank you
We’ve hit 5.000 followers on LinkedIn, and we couldn’t be more grateful. To all of you who read, like, comment, and share our content – thank you for being part of our journey! We’re proud of how far we’ve come, and even more excited about where we’re going. Let’s keep growing ...
News
EuroELSO 2025
A heartfelt thank you to everyone who participated in the EuroELSO Congress 2025! We are truly grateful for the insightful discussions and inspiring connections made during the event. Looking ahead, we’re already excited for the upcoming congresses and opportunities to further advance healthcare together!
PICU NICU 2025
A big thank you to all the participants of the 15th European Postgraduate Course in Neonatal and Pediatric Intensive Care Medicine in Bern! It has been a fantastic experience connecting with you all, sharing knowledge, and discussing the future of neonatal and pediatric intensive care. Your insights and dedication to ...
Events
20. – 23. May
EuroPCR 2025
The World-Leading Course in interventional cardiovascular medicine
Visit our booth!
https://www.pcronline.com/Courses/EuroPCR
Venue
Palais des congrès, Paris, France
25. – 28. June
ESPNIC 2025
The Paediatric and Neonatal Intensive Care Congress brings PICU & NICU teams together
https://www.mcascientificevents.eu/espnic/
Venue
Auditorio de la diputación de Alicante, Spain
08. – 11. October
EACTS 2025
39th EACTS (European Association for Cardio-Thoracic Surgery) Annual Meeting
https://www.eacts.org/39th-eacts-annual-meeting/
Venue
Bella Center Copenhagen, Denmark
25. – 29. October
ESICM LIVES 2025
38th ESICM's (European Society Of Intensive Care Medicine) annual congress - LIVES
Visit our booth!
https://www.esicm.org/events/38th-annual-congress-munich/
Venue
ICM, International Congress Centre Munich, Germany
[1] ELSO Guidelines for Cardiopulmonary Extracorporeal Life Support. Extracorporeal Life Support Organization, Version 1.4 August 2017, Ann Arbor, MI, USA
[2] Peek, G. et al. (2009). Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet, 374(9698), 1351–1363
[3] Combes, A. et al. (2018). Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome. N Engl J Med, 378(21), 1965–1975